Logo Logo Logo Logo Logo
  • Vyriad Home
  • Pipeline
  • Technology
    • Technology Overview
    • VSV Platform
    • Measles Platform
  • News & Events
    • Press Releases
    • In the News
    • Events
    • Video/Audio
  • About
    • About Vyriad
    • Management Team
    • Board of Directors
  • Contact Us
  • Vyriad Home
  • Pipeline
  • Technology

    • Technology Overview
    • VSV Platform
    • Measles Platform
  • News & Events

    • Press Releases
    • In the News
    • Events
    • Video/Audio
  • About

    • About Vyriad
    • Management Team
    • Board of Directors
  • Contact Us

Video/Audio

Video/Audio

2019
  • November 8, 2019

    Radio interview with Dr. Stephen Russell on Rochester Today

    KROC 1340 AM

    Vyriad CEO Stephen Russell, MD, PhD discusses the company’s strategic partnership with biopharmaceutical leader Regeneron

2018
  • April 9-12, 2018

    The Great Oncolytic Debate: For the success of oncolytic viruses – single cycle cures or repeat treatments?

    Oxford, UK

    Stephen J. Russell, M.D., Ph.D., Vyriad CEO, has been invited to Chair, Innate and collateral adaptive tumor immunity. Dr. Russell will also participate in Steve Russell (Once should be enough!) vs. Alan Melcher (Repeat dosing is crucial!)

  • June 26, 2016

    This Week in Virology

    TWIV

    Video podcast with featured guest Stephen Russell, MD, PhD, CEO & President of Vyriad

  • February 27, 2015

    Star Tribune

    “VICE Special Report: Killing Cancer”

  • October 24, 2014

    Mayo Clinic

    Serendipity: How a Cancer-Fighting Measles Virus Brought Together Patient and Benefactors

Copyright 2017. All Rights Reserved.
site by Strut Branding.